38 - Safety considerations in the generation of clinical grade autologous ips cell lines
Autor: | Anderson, H. *, Daheron, L., Savvidis, G., Negre, H., Nag, A., Thorner, A., Liu, X., Gu, S., Hu, X., Kelley, M., Chow, S., Daley, H., Manduke, R., Hwa, A., Pagliuca, F., Ritz, J. |
---|---|
Zdroj: | In Cytotherapy May 2018 20(5) Supplement:S21-S21 |
Databáze: | ScienceDirect |
Externí odkaz: |